NDAORALPASTE
Approved
Oct 2016
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
VARIBAR PUDDING (barium sulfate) by Bracco is x-ray contrast activity [moa]. Approved for radiographic contrast agent [epc]. First approved in 2016.
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VARIBAR PUDDING is an oral barium sulfate paste formulation used as a radiographic contrast agent for diagnostic imaging studies. It works by providing radiopacity to visualize the gastrointestinal tract during X-ray procedures. The pudding consistency allows for easy swallowing and better coating of esophageal and pharyngeal structures during fluoroscopic examination.
Peak
VARIBAR PUDDING operates at peak market maturity as a specialty diagnostic imaging contrast agent; Bracco's diagnostic portfolio supports steady demand but limited team expansion opportunities.
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Indications (1)
Career Relevance
Working on VARIBAR PUDDING positions professionals in a stable, mature diagnostic imaging franchise with established clinical utility and institutional relationships. Career growth depends on operational excellence, market share defense, and cross-functional collaboration within Bracco's broader contrast portfolio rather than new molecule innovation.
Worked on VARIBAR PUDDING at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.